Interplay of chronic obstructive pulmonary disease and colorectal cancer development: unravelling the mediating role of fatty acids through a comprehensive multi-omics analysis.
Chronic obstructive pulmonary disease
Colorectal cancer
Fatty acid
Mediating factor
Multi-omics
Journal
Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
received:
13
04
2023
accepted:
14
06
2023
medline:
4
9
2023
pubmed:
2
9
2023
entrez:
1
9
2023
Statut:
epublish
Résumé
Chronic obstructive pulmonary disease (COPD) patients often exhibit gastrointestinal symptoms, A potential association between COPD and Colorectal Cancer (CRC) has been indicated, warranting further examination. In this study, we collected COPD and CRC data from the National Health and Nutrition Examination Survey, genome-wide association studies, and RNA sequence for a comprehensive analysis. We used weighted logistic regression to explore the association between COPD and CRC incidence risk. Mendelian randomization analysis was performed to assess the causal relationship between COPD and CRC, and cross-phenotype meta-analysis was conducted to pinpoint crucial loci. Multivariable mendelian randomization was used to uncover mediating factors connecting the two diseases. Our results were validated using both NHANES and GEO databases. In our analysis of the NHANES dataset, we identified COPD as a significant contributing factor to CRC development. MR analysis revealed that COPD increased the risk of CRC onset and progression (OR: 1.16, 95% CI 1.01-1.36). Cross-phenotype meta-analysis identified four critical genes associated with both CRC and COPD. Multivariable Mendelian randomization suggested body fat percentage, omega-3, omega-6, and the omega-3 to omega-6 ratio as potential mediating factors for both diseases, a finding consistent with the NHANES dataset. Further, the interrelation between fatty acid-related modules in COPD and CRC was demonstrated via weighted gene co-expression network analysis and Kyoto Encyclopedia of Genes and Genomes enrichment results using RNA expression data. This study provides novel insights into the interplay between COPD and CRC, highlighting the potential impact of COPD on the development of CRC. The identification of shared genes and mediating factors related to fatty acid metabolism deepens our understanding of the underlying mechanisms connecting these two diseases.
Sections du résumé
BACKGROUND
Chronic obstructive pulmonary disease (COPD) patients often exhibit gastrointestinal symptoms, A potential association between COPD and Colorectal Cancer (CRC) has been indicated, warranting further examination.
METHODS
In this study, we collected COPD and CRC data from the National Health and Nutrition Examination Survey, genome-wide association studies, and RNA sequence for a comprehensive analysis. We used weighted logistic regression to explore the association between COPD and CRC incidence risk. Mendelian randomization analysis was performed to assess the causal relationship between COPD and CRC, and cross-phenotype meta-analysis was conducted to pinpoint crucial loci. Multivariable mendelian randomization was used to uncover mediating factors connecting the two diseases. Our results were validated using both NHANES and GEO databases.
RESULTS
In our analysis of the NHANES dataset, we identified COPD as a significant contributing factor to CRC development. MR analysis revealed that COPD increased the risk of CRC onset and progression (OR: 1.16, 95% CI 1.01-1.36). Cross-phenotype meta-analysis identified four critical genes associated with both CRC and COPD. Multivariable Mendelian randomization suggested body fat percentage, omega-3, omega-6, and the omega-3 to omega-6 ratio as potential mediating factors for both diseases, a finding consistent with the NHANES dataset. Further, the interrelation between fatty acid-related modules in COPD and CRC was demonstrated via weighted gene co-expression network analysis and Kyoto Encyclopedia of Genes and Genomes enrichment results using RNA expression data.
CONCLUSIONS
This study provides novel insights into the interplay between COPD and CRC, highlighting the potential impact of COPD on the development of CRC. The identification of shared genes and mediating factors related to fatty acid metabolism deepens our understanding of the underlying mechanisms connecting these two diseases.
Identifiants
pubmed: 37658368
doi: 10.1186/s12967-023-04278-1
pii: 10.1186/s12967-023-04278-1
pmc: PMC10474711
doi:
Substances chimiques
Fatty Acids
0
Types de publication
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
587Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Gut. 2017 Oct;66(10):1790-1796
pubmed: 27436272
BMJ. 2017 Jun 15;357:j2497
pubmed: 28620089
Cell Rep. 2021 Jun 8;35(10):109212
pubmed: 34107251
J Nutr Biochem. 2012 Jul;23(7):817-21
pubmed: 21889886
EMBO J. 2017 May 15;36(10):1412-1433
pubmed: 28377464
Nucleic Acids Res. 1999 Jan 1;27(1):29-34
pubmed: 9847135
JAMA. 2006 Jan 25;295(4):403-15
pubmed: 16434631
Gastroenterology. 2021 Jul;161(1):171-184.e10
pubmed: 33744305
J Hematol Oncol. 2020 Dec 4;13(1):166
pubmed: 33276803
Am J Respir Crit Care Med. 2023 May 1;207(9):1145-1160
pubmed: 36883945
Int J Chron Obstruct Pulmon Dis. 2020 Jul 10;15:1633-1642
pubmed: 32764909
Genome Biol. 2017 May 5;18(1):83
pubmed: 28476144
BMC Cardiovasc Disord. 2021 Sep 1;21(1):417
pubmed: 34470611
Ann Am Thorac Soc. 2018 Oct;15(10):1240
pubmed: 30016124
Eur Respir J. 2003 Oct;22(4):672-88
pubmed: 14582923
Int J Mol Sci. 2022 Sep 16;23(18):
pubmed: 36142720
BMJ. 2015 Feb 03;350:h286
pubmed: 25649042
Int J Environ Res Public Health. 2021 Aug 19;18(16):
pubmed: 34444491
BMC Pulm Med. 2020 Jun 15;20(1):170
pubmed: 32539764
Lancet Respir Med. 2022 May;10(5):447-458
pubmed: 35279265
Thorax. 2019 Feb;74(2):132-140
pubmed: 30366970
Am J Hum Genet. 2012 May 4;90(5):821-35
pubmed: 22560090
Cold Spring Harb Perspect Med. 2021 Feb 1;11(2):
pubmed: 32341063
J Allergy Clin Immunol. 2016 Jul;138(1):16-27
pubmed: 27373322
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1090-1098
pubmed: 30649496
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Biomed Pharmacother. 2002 Oct;56(8):365-79
pubmed: 12442909
Brain. 2022 Oct 21;145(10):3444-3453
pubmed: 35656776
Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):860-870
pubmed: 32051193
EBioMedicine. 2021 Jun;68:103397
pubmed: 34051439
Respir Res. 2018 Nov 3;19(1):211
pubmed: 30390648
Chest. 2014 Feb;145(2):199-200
pubmed: 24493496
Chest. 2018 Jun;153(6):1497-1498
pubmed: 29884254
Cell Rep. 2022 Dec 13;41(11):111755
pubmed: 36516771
Chest. 2014 Feb;145(2):245-252
pubmed: 23928850
Nat Rev Genet. 2008 Jun;9(6):477-85
pubmed: 18427557
Genes Dev. 2021 Jun;35(11-12):787-820
pubmed: 34074695
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Clin Nutr. 2021 Apr;40(4):2270-2277
pubmed: 33873268
BMC Med. 2018 Oct 26;16(1):188
pubmed: 30360759
Nat Genet. 2019 Jan;51(1):76-87
pubmed: 30510241
Cancers (Basel). 2021 Sep 18;13(18):
pubmed: 34572920
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
JAMA. 2012 Dec 12;308(22):2361-8
pubmed: 23232894
Cell Genom. 2022 Oct 12;2(10):100192
pubmed: 36777996
Diabetologia. 2007 May;50(5):934-40
pubmed: 17119914
Gut. 2012 Jan;61(1):135-49
pubmed: 21490374
J Am Soc Nephrol. 2016 Nov;27(11):3253-3265
pubmed: 27486138
Sheng Wu Gong Cheng Xue Bao. 2022 Oct 25;38(10):3581-3593
pubmed: 36305394
Cancers (Basel). 2021 Sep 21;13(18):
pubmed: 34572955
Nat Commun. 2020 Nov 18;11(1):5886
pubmed: 33208745
Biochim Biophys Acta. 2001 Nov 26;1550(1):37-51
pubmed: 11738086